Alcohol in the Treatment of Obesity
This pilot study looks at the relationship of moderate alcohol consumption on weight loss.
Description
We hypothesize that individuals who consume a moderate amount of alcohol, such as a glass or two of wine daily, will lose more during a weight-reduction program than will those who do not, if equal calories are administered to both groups. The purpose of this pilot study is to look at the relationship of alcohol in weight loss. The current standard in weight loss programs is to eliminate alcohol from the diet. We propose to enroll 50 females enrolled at the Structure House residential diet program in Durham, NC. Half or the subjects will receive 150 calories in the form of white wine, 3.5 ounce with lunch and 3.5 ounces with dinner. The other half of the subjects wil receive their 150 calories in their regular diet. All participants are asked not to consume any additional alcohol. Participants will be weighed daily. The study lasts four weeks.
Status: Terminated (N/A). Started on April 1st, 2007. Ended on December 1st, 2008.
Enrollment: 50 subjects
Study Type: Interventional
Study Design:
- Other
- Randomized
- Open Label
- Parallel Assignment
Conditions:
Interventions:
- Other: white wine
- Other: white wine
Eligibility
Inclusion Criteria:
Age >21, female, BMI ≥ 30, no history of substance abuse, prior alcohol use of at least one drink/week; Exclusion:
pregnancy, breast feeding, previous history of alcohol abuse, liver disease.
- Gender
Female
- Mininum Age
21 Years
- Maximum Age
N/A
- Healthy Volunteers
Accepts Healthy Volunteers
Resources
Source: Duke University
Authority: United States: Institutional Review Board
Locations
-
Structure House, LLC
Durham
North Carolina
27705
United States
Officials
Richard S Surwit, Ph.D., ABPP, (Principal Investigator, Duke University)
Sponsors
Duke University (Lead Sponsor)
References
None.
Links
None.
- Date Verified
- June 1st, 2008
- First Received
- June 3rd, 2008
- Last Changed
- June 3rd, 2008
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.